These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Abnormal angiopoietins 1&2, angiopoietin receptor Tie-2 and vascular endothelial growth factor levels in hypertension: relationship to target organ damage [a sub-study of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)]. Nadar SK; Blann A; Beevers DG; Lip GY J Intern Med; 2005 Oct; 258(4):336-43. PubMed ID: 16164572 [TBL] [Abstract][Full Text] [Related]
3. Plasma angiopoietin-1, angiopoietin-2, angiopoietin receptor tie-2, and vascular endothelial growth factor levels in acute coronary syndromes. Lee KW; Lip GY; Blann AD Circulation; 2004 Oct; 110(16):2355-60. PubMed ID: 15302795 [TBL] [Abstract][Full Text] [Related]
4. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade. Lip PL; Chatterjee S; Caine GJ; Hope-Ross M; Gibson J; Blann AD; Lip GY Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809 [TBL] [Abstract][Full Text] [Related]
5. Plasma markers of angiogenesis in pregnancy induced hypertension. Nadar SK; Karalis I; Al Yemeni E; Blann AD; Lip GY Thromb Haemost; 2005 Nov; 94(5):1071-6. PubMed ID: 16363251 [TBL] [Abstract][Full Text] [Related]
6. Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure. Eleuteri E; Di Stefano A; Tarro Genta F; Vicari C; Gnemmi I; Colombo M; Mezzani A; Giannuzzi P Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):607-14. PubMed ID: 21450636 [TBL] [Abstract][Full Text] [Related]
7. Potential role of soluble angiopoietin-2 and Tie-2 in patients with inflammatory bowel disease. Koutroubakis IE; Xidakis C; Karmiris K; Sfiridaki A; Kandidaki E; Kouroumalis EA Eur J Clin Invest; 2006 Feb; 36(2):127-32. PubMed ID: 16436095 [TBL] [Abstract][Full Text] [Related]
8. The angiopoietin/Tie-2 system in proliferative sickle retinopathy: relation to vascular endothelial growth factor, its soluble receptor Flt-1 and von Willebrand factor, and to the effects of laser treatment. Mohan JS; Lip PL; Blann AD; Bareford D; Lip GY Br J Ophthalmol; 2005 Jul; 89(7):815-9. PubMed ID: 15965157 [TBL] [Abstract][Full Text] [Related]
9. Changes in plasma vascular endothelial growth factor, angiopoietins, and their receptors following surgery for breast cancer. Caine GJ; Stonelake PS; Lip GY; Blann AD Cancer Lett; 2007 Apr; 248(1):131-6. PubMed ID: 16891056 [TBL] [Abstract][Full Text] [Related]
10. Angiopoietin 1 (Ang-1), angiopoietin 2 (Ang-2) and Tie-2 (a receptor tyrosine kinase) concentrations in peripheral blood of patients with thyroid cancers. Niedźwiecki S; Stepień T; Kopeć K; Kuzdak K; Komorowski J; Krupiński R; Stepień H Cytokine; 2006 Dec; 36(5-6):291-5. PubMed ID: 17374490 [TBL] [Abstract][Full Text] [Related]
11. Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia. Lee CY; Tien HF; Hu CY; Chou WC; Lin LI Br J Cancer; 2007 Oct; 97(7):877-82. PubMed ID: 17848952 [TBL] [Abstract][Full Text] [Related]
12. Angiogenic factors in atrial fibrillation: a possible role in thrombogenesis? Freestone B; Chong AY; Lim HS; Blann A; Lip GY Ann Med; 2005; 37(5):365-72. PubMed ID: 16179272 [TBL] [Abstract][Full Text] [Related]
13. Changes in vascular endothelial growth factor, angiopoietins, and Tie-2 levels with G-CSF stimulation in healthy donors. Serefhanoglu S; Goker H; Buyukasik Y; Turgut M; Sayinalp N; Haznedaroglu IC; Aksu S; Akman U; Ozcebe OI Ann Hematol; 2009 Jul; 88(7):667-71. PubMed ID: 19082594 [TBL] [Abstract][Full Text] [Related]
14. Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1. Caine GJ; Blann AD; Stonelake PS; Ryan P; Lip GY Eur J Clin Invest; 2003 Oct; 33(10):883-90. PubMed ID: 14511360 [TBL] [Abstract][Full Text] [Related]
15. Plasma and platelet-derived vascular endothelial growth factor and angiopoietin-1 in hypertension: effects of antihypertensive therapy. Nadar SK; Blann AD; Lip GY J Intern Med; 2004 Oct; 256(4):331-7. PubMed ID: 15367176 [TBL] [Abstract][Full Text] [Related]
16. Effects of aspirin on intra-platelet vascular endothelial growth factor, angiopoietin-1, and p-selectin levels in hypertensive patients. Nadar S; Blann AD; Lip GY Am J Hypertens; 2006 Sep; 19(9):970-7; discussion 978. PubMed ID: 16942942 [TBL] [Abstract][Full Text] [Related]
17. Angiopoietin 2 and cardiovascular disease in dialysis and kidney transplantation. David S; Kümpers P; Hellpap J; Horn R; Leitolf H; Haller H; Kielstein JT Am J Kidney Dis; 2009 May; 53(5):770-8. PubMed ID: 19268412 [TBL] [Abstract][Full Text] [Related]
18. Systemic and intracardiac vascular endothelial growth factor and angiopoietin-1 and -2 levels in coronary artery disease: effects of angioplasty. Jaumdally RJ; Varma C; Blann AD; MacFadyen RJ; Lip GY Ann Med; 2007; 39(4):298-305. PubMed ID: 17558601 [TBL] [Abstract][Full Text] [Related]
19. Serum levels of angiopoietin-1, angiopoietin-2, and their receptor tie-2 in patients with nonsmall cell lung cancer during chemotherapy. Naumnik W; Chyczewska E; Ossolinska M Cancer Invest; 2009 Aug; 27(7):741-6. PubMed ID: 19340656 [TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations of angiopoietin-1, angiopoietin-2 and Tie-2 in colon cancer. Engin H; Üstündağ Y; Tekin İÖ; Gökmen A; Ertop Ş; İlikhan SU Eur Cytokine Netw; 2012 Jun; 23(2):68-71. PubMed ID: 22728324 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]